Bioaffinity Technologiew-27BIAFWPreferred / convertible
13F holders, Q3 2024 (September 30)4holders
1new positions
1sold out
1famous investor
$1.15avg. 13F price*
At the end of Q3 2024, 4 institutions reported holding Bioaffinity Technologiew-27 (BIAFW) in their 13F filings, unchanged from Q2 2024. 1 opened new positions and 1 sold out. The largest holders were Armistice Capital, LLC ($235K), Clear Street LLC ($63K) and Citadel Advisors ($45K). One famous investor held it Ken Griffin ( of Citadel Advisors's portfolio).
- Company
- Bioaffinity Technologiew-27
- CUSIP
- 09076W117
- Latest filing quarter
- Q2 2026
History
Number of 13F holders
Total Exit/New Position Q2 2024 → Q3 2024
| Institutions | Total Value | |
|---|---|---|
| New Positions | 1 | $537 |
| Exits | 1 | $6K |
All 13F filers, Q2 2024 → Q3 2024: 17,426 shares bought and 25,559 shares sold, net −8,133 shares. Counts holders who added, trimmed, opened or closed a position; split-adjusted.
Ownership 4 holders
| Armistice Capital, LLC | — | No change | 204,082 | $235K |
| Clear Street LLC | — | Reduce -16.8% | 54,933 | $63K |
| Citadel Advisors | — | Add +76.3% | 39,180 | $45K |
| UBS Group AG | — | New | 467 | $537 |
"% of holder's portfolio" is BIAFW's weight in each manager's 13F, not the share of Bioaffinity Technologiew-27 the manager owns.